AI-Native Antiviral Discovery

Drug discovery for viruses that

An AI-native platform purpose-built for viral targets that have historically resisted small-molecule intervention. First-in-class antivirals against the most dangerous pathogens on earth.

Contact Investors veloran.bio
4
Programs in
Lead Optimization
25+
Viral Species
Mapped
$2.5M
Seed Round
Open
◆ ViralPocketMap™ ◆ DIPL Predictor™ ◆ ADMET Suite™ ◆ BSL-4 Pathogens ◆ Lead Optimization ◆ AI-Native Discovery ◆ First-In-Class Antivirals ◆ Cryptic Binding Sites ◆ $2.5M Seed Round ◆ ViralPocketMap™ ◆ DIPL Predictor™ ◆ ADMET Suite™ ◆ BSL-4 Pathogens ◆ Lead Optimization ◆ AI-Native Discovery ◆ First-In-Class Antivirals ◆ Cryptic Binding Sites ◆ $2.5M Seed Round

The antiviral platform for threats the world isn't ready for.

We're raising a $2.5M seed round. If you invest in computational biotech or early-stage drug discovery, we'd like to talk.

→ $2.5M Seed  ·  SAFE or Priced Round
→ ceb24k@fsu.edu
→ veloran.bio